Skip to Main Content

Author Details

Philip J Norris
Vitalant Research Institute
2001
184
51
PMIDPaper TitleJournal TitlePublished Year
37976448Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo.Blood2024
38054619Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination.Transfusion2024
36862515COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response.JCI Insight2023
37250174Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras.Open Forum Infect Dis2023
37005979Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV.J Neurovirol2023
36648237A Stable Dried Tube Specimen for Quality Assurance and Training Programs for HIV Rapid Test for Recent Infection.Microbiol Spectr2023
36469038Sphingosine 1-phosphate has a negative effect on RBC storage quality.Blood Adv2023
36840440Risk of HLA antibody generation after receipt of Mirasol versus standard platelets in the MIPLATE randomized trial.Transfusion2023
36934200Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV.J Neurovirol2023
35309313Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Front Immunol2022
35584677A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection.Cell Rep2022
35441384The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.Transfusion2022
35834347Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.J Clin Invest2022
35435733Plasma CD16<sup>+</sup> Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV<sup>+</sup> Adults on Combination Antiretroviral Therapy.mBio2022
36601110Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment.Front Immunol2022
34985329Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.Microbiol Spectr2022
33320240Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury.J Infect Dis2021
33758859Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs.bioRxiv2021
33503656Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles.Anesthesiology2021
33748497Comparison of multiplex cytokine assays in a pediatric cohort with epilepsy.Heliyon2021
34405093Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019.Open Forum Infect Dis2021
34429372Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.Sci Transl Med2021
34454842Reduced dimethyl sulfoxide concentrations successfully cryopreserve human hematopoietic stem cells with multi-lineage long-term engraftment ability in mice.Cytotherapy2021
34155359A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.Bone Marrow Transplant2021
33983973Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.PLoS One2021
34009544Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma.J Clin Immunol2021
34330709SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.Sci Adv2021
32511302Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray.bioRxiv2020
31725429Serum extracellular vesicles expressing bone activity markers associate with bone loss after HIV antiretroviral therapy.AIDS2020
32995758ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.Cell Rep Med2020
32753403Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.Immunohorizons2020
32219408Seminal plasma promotes decidualization of endometrial stromal fibroblasts in vitro from women with and without inflammatory disorders in a manner dependent on interleukin-11 signaling.Hum Reprod2020
32390808Early Inflammatory Signatures Predict Subsequent Cognition in Long-Term Virally Suppressed Women With HIV.Front Integr Neurosci2020
32246477INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies.Transfusion2020
32175087Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.J Virus Erad2020
32434889Seminal Plasma-Derived Extracellular-Vesicle Fractions from HIV-Infected Men Exhibit Unique MicroRNA Signatures and Induce a Proinflammatory Response in Cells Isolated from the Female Reproductive Tract.J Virol2020
32267841Influence of sickle cell disease on susceptibility to HIV infection.PLoS One2020
32166810Red-blood-cell manufacturing methods and storage solutions differentially induce pulmonary cell activation.Vox Sang2020
30499599The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.Transfusion2019
31266863Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice.mBio2019
31321294Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations.Transplant Direct2019
31518003Lack of persistent microchimerism in contemporary transfused trauma patients.Transfusion2019
30835880Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery.Transfusion2019
30882927Influence of blood storage age on immune and coagulation parameters in critically ill transfused patients.Transfusion2019
30882919Therapeutic impact of red blood cell transfusion on anemic outpatients: the RETRO study.Transfusion2019
30995929Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.J Transl Med2019
30427537Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).Transfusion2019
29063513Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study.J Neurovirol2018
29867942Granulocyte-Derived Extracellular Vesicles Activate Monocytes and Are Associated With Mortality in Intensive Care Unit Patients.Front Immunol2018
30217795Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.Blood Adv2018
  • 1 - 50 of 184

Recommended Authors

Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 3
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 7
Cardiovascular Research Institute, University of California san francisco
Career Start Year 2006
Number of shared co-authors 5
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 2
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 17
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 7
College of Medicine, University of Arizona
Career Start Year 1994
Number of shared co-authors 3
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 11
University College London
Career Start Year 1992
Number of shared co-authors 1
Frederick National Laboratory for Cancer Research
Career Start Year 1991
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 11
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 11
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 6
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
University of Washington
Career Start Year 1986
Number of shared co-authors 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 5
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 7
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 15
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 6
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 12
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 16
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 1972
Number of shared co-authors 6
Wistar Institute
Career Start Year 1958
Number of shared co-authors 4

Collaborators

Vitalant Research Institute
Co-authored papers 58
University of California San Francisco
Co-authored papers 38
Vitalant Research Institute
Co-authored papers 20
Cerus Corporation
Co-authored papers 18
University of British Columbia
Co-authored papers 17
Co-authored papers 15
Vitalant Research Institute
Co-authored papers 14
Co-authored papers 13
University of California san francisco
Co-authored papers 13
Pittsburgh University
Co-authored papers 12
Co-authored papers 10
Co-authored papers 9
Co-authored papers 8
University of Pittsburgh
Co-authored papers 8
Co-authored papers 8
Ragon Institute of Mass General
Co-authored papers 7
Scientific Services
Co-authored papers 7
Co-authored papers 6
Yale University
Co-authored papers 6
0Nationwide Children's Hospital
Co-authored papers 5
Co-authored papers 5
University of Alberta
Co-authored papers 5
Clinical Sciences
Co-authored papers 5
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 5
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
University of California San Francisco
Co-authored papers 4
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Sainte Justine and Montreal Heart Institute, University of Montreal
Co-authored papers 4